Us Food And Drug Administration Usfda
- All
- News
- Videos
-
Glenmark Pharmaceuticals Recalls 1,200 Bottles Of "Subpotent" Hypertension Drug In US
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
-
US Approves Lab-Grown Chicken To Be Sold In Markets, Twitter Reacts
The United States Department of Agriculture (USDA) has granted approvals to two companies selling chicken grown from animal cells.
-
Elon Musk Expects Brain-Chip Startup Neuralink to Start First Human Trial This Year
Elon Musk expects his brain-chip startup Neuralink to start its first human trial this year, he said on Friday. While Musk didn't specify how many patients his company would implant or for how long, "it's looking like the first case will be later this year," said Musk.
-
Zydus Gets US Regulator's Approval For Blood Pressure Medication
Zydus Lifesciences on Thursday said it received final approval from the US Food and Drug Administration (FDA) to manufacture and market Metoprolol Tartrate tablets in dosages of 25 mg, 50 mg, and 100 mg
-
Biocon Recalls 3,665 Bottles Of Antifungal Drug In US For "Failed Specifications"
Biotechnology major Biocon is recalling 3,665 bottles of antifungal medication in the US market for "failed degradation specifications", according to the US Food and Drug Administration (USFDA).
-
Starbucks Vanilla Frappuccino Bottles In US Recalled Over Health Safety Concerns
The US Food and Drug Administration said that more than 25,000 cases of the glass bottles have been recalled.
-
Aurobindo Pharma Recalls Products In US Market For Manufacturing Lapses
Aurobindo Pharma units are recalling different products in the US market for manufacturing lapses, as per the US health regulator.
-
Moderna Submits Application Before US Regulator For Covid Booster Shot
Moderna on Wednesday announced it had begun submitting an application to the US Food and Drug Administration to authorize a booster of its Covid vaccine after trial data showed a significant increase in antibodies against variants.
-
Marksans Pharma Shares Gain On USFDA Approval For Pain Killer Drug
Marksans will manufacture the products at its US Food and Drug Administration (USFDA) approved solid oral dosage facility located at Goa.
-
US Drug Regulator Investigating 5 Allergic Reactions After Pfizer Shot
The US Food and Drug Administration is investigating around five allergic reactions that happened after people were administered Pfizer Inc and BioNTech SE's COVID-19 vaccine in the United States this week, a top FDA official said late on Friday.
-
US Drug Regulator Recommends Emergency Approval Of Moderna Vaccine
The US Food and Drug Administration (FDA) will "rapidly" work towards granting emergency approval of Moderna Inc's COVID-19 vaccine candidate, FDA Commissioner Stephen Hahn said on Thursday.
-
US Gives Full Approval To Antiviral Drug Remdesivir To Treat COVID-19
The US Food and Drug Administration on Thursday granted full approval to the antiviral drug remdesivir as a treatment for patients hospitalized with Covid-19, after conditional authorization was given in May.
-
Cipla Shares Fall 6% After US Regulator's Warning Letter On Goa Facility
Cipla Share Price: Cipla said it will work closely with the US Food and Drug Administration (FDA) to comprehensively address all the observations.
-
MDH Sambar Masala Fails US FDA Test, Three Lots Recalled: Make Everyday Masalas At Home (Recipes Inside)
The US Food and Drug Administration (US FDA) has found salmonella bacteria in MDH sambar masala, following which the products were recalled from the US earlier this week. Make everyday masalas at home with these easy recipes.
-
USFDA issues Warning Letter To Divis Labs For Vishakhapatnam Unit
The United States Food and Drug Administration (USFDA) has issued warning letter for the company's Unit-II at Vishakhapatnam, Divis Laboratories said in a BSE filing.
-
Glenmark Pharmaceuticals Recalls 1,200 Bottles Of "Subpotent" Hypertension Drug In US
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
-
US Approves Lab-Grown Chicken To Be Sold In Markets, Twitter Reacts
The United States Department of Agriculture (USDA) has granted approvals to two companies selling chicken grown from animal cells.
-
Elon Musk Expects Brain-Chip Startup Neuralink to Start First Human Trial This Year
Elon Musk expects his brain-chip startup Neuralink to start its first human trial this year, he said on Friday. While Musk didn't specify how many patients his company would implant or for how long, "it's looking like the first case will be later this year," said Musk.
-
Zydus Gets US Regulator's Approval For Blood Pressure Medication
Zydus Lifesciences on Thursday said it received final approval from the US Food and Drug Administration (FDA) to manufacture and market Metoprolol Tartrate tablets in dosages of 25 mg, 50 mg, and 100 mg
-
Biocon Recalls 3,665 Bottles Of Antifungal Drug In US For "Failed Specifications"
Biotechnology major Biocon is recalling 3,665 bottles of antifungal medication in the US market for "failed degradation specifications", according to the US Food and Drug Administration (USFDA).
-
Starbucks Vanilla Frappuccino Bottles In US Recalled Over Health Safety Concerns
The US Food and Drug Administration said that more than 25,000 cases of the glass bottles have been recalled.
-
Aurobindo Pharma Recalls Products In US Market For Manufacturing Lapses
Aurobindo Pharma units are recalling different products in the US market for manufacturing lapses, as per the US health regulator.
-
Moderna Submits Application Before US Regulator For Covid Booster Shot
Moderna on Wednesday announced it had begun submitting an application to the US Food and Drug Administration to authorize a booster of its Covid vaccine after trial data showed a significant increase in antibodies against variants.
-
Marksans Pharma Shares Gain On USFDA Approval For Pain Killer Drug
Marksans will manufacture the products at its US Food and Drug Administration (USFDA) approved solid oral dosage facility located at Goa.
-
US Drug Regulator Investigating 5 Allergic Reactions After Pfizer Shot
The US Food and Drug Administration is investigating around five allergic reactions that happened after people were administered Pfizer Inc and BioNTech SE's COVID-19 vaccine in the United States this week, a top FDA official said late on Friday.
-
US Drug Regulator Recommends Emergency Approval Of Moderna Vaccine
The US Food and Drug Administration (FDA) will "rapidly" work towards granting emergency approval of Moderna Inc's COVID-19 vaccine candidate, FDA Commissioner Stephen Hahn said on Thursday.
-
US Gives Full Approval To Antiviral Drug Remdesivir To Treat COVID-19
The US Food and Drug Administration on Thursday granted full approval to the antiviral drug remdesivir as a treatment for patients hospitalized with Covid-19, after conditional authorization was given in May.
-
Cipla Shares Fall 6% After US Regulator's Warning Letter On Goa Facility
Cipla Share Price: Cipla said it will work closely with the US Food and Drug Administration (FDA) to comprehensively address all the observations.
-
MDH Sambar Masala Fails US FDA Test, Three Lots Recalled: Make Everyday Masalas At Home (Recipes Inside)
The US Food and Drug Administration (US FDA) has found salmonella bacteria in MDH sambar masala, following which the products were recalled from the US earlier this week. Make everyday masalas at home with these easy recipes.
-
USFDA issues Warning Letter To Divis Labs For Vishakhapatnam Unit
The United States Food and Drug Administration (USFDA) has issued warning letter for the company's Unit-II at Vishakhapatnam, Divis Laboratories said in a BSE filing.
